Zdrowie i gospodarka · 17/12/2015

FDA Releases Draft Guidance on Safety Assessment for Investigational New Drug Application Safety Reporting

The Food and Drug Administration (FDA) has made available a draft guidance for industry on developing a systematic approach to safety reporting for investigational new drug applications (INDs), a follow-up to its previous guidance on safety reporting requirements for INDs and bioequivalence studies.